This company listing is no longer active
Biofrontera Crecimiento futuro
Future controles de criterios 5/6
Información clave
44.5%
Tasa de crecimiento de los beneficios
42.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 21.4% |
Tasa de crecimiento de los ingresos | 22.0% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2024 | 40 | 3 | 1 | 2 | 1 |
12/31/2023 | 31 | 0 | -4 | -3 | 1 |
12/31/2022 | 26 | -38 | -9 | -9 | 1 |
6/30/2022 | 31 | 10 | 33 | 33 | N/A |
3/31/2022 | 30 | 15 | N/A | N/A | N/A |
12/31/2021 | 29 | 38 | 30 | 30 | N/A |
9/30/2021 | 28 | -16 | N/A | N/A | N/A |
6/30/2021 | 27 | -16 | -8 | -7 | N/A |
3/31/2021 | 29 | -12 | N/A | N/A | N/A |
12/31/2020 | 30 | -13 | -4 | -3 | N/A |
9/30/2020 | 33 | -17 | N/A | N/A | N/A |
6/30/2020 | 33 | -22 | -14 | -12 | N/A |
3/31/2020 | 31 | -10 | N/A | N/A | N/A |
12/31/2019 | 31 | -7 | -35 | -33 | N/A |
9/30/2019 | 26 | 1 | N/A | N/A | N/A |
6/30/2019 | 26 | 8 | -29 | -28 | N/A |
3/31/2019 | 23 | -8 | N/A | N/A | N/A |
12/31/2018 | 21 | -9 | -14 | -13 | N/A |
9/30/2018 | 19 | -14 | -13 | -13 | N/A |
6/30/2018 | 16 | -15 | -12 | -12 | N/A |
3/31/2018 | 14 | -16 | N/A | N/A | N/A |
12/31/2017 | 12 | -16 | -14 | -13 | N/A |
9/30/2017 | 11 | -18 | -16 | -16 | N/A |
6/30/2017 | 9 | -16 | -16 | -16 | N/A |
3/31/2017 | 8 | -14 | -15 | -15 | N/A |
12/31/2016 | 6 | -11 | -11 | -10 | N/A |
9/30/2016 | 4 | -9 | -9 | -8 | N/A |
6/30/2016 | 4 | -7 | -6 | -6 | N/A |
3/31/2016 | 4 | -9 | N/A | -8 | N/A |
12/31/2015 | 4 | -11 | N/A | -10 | N/A |
9/30/2015 | 4 | -12 | N/A | -10 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: B8FE's forecast earnings growth (44.5% per year) is above the savings rate (-0.01%).
Beneficios vs. Mercado: B8FE's earnings (44.5% per year) are forecast to grow faster than the German market (9.8% per year).
Beneficios de alto crecimiento: B8FE's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: B8FE's revenue (22% per year) is forecast to grow faster than the German market (3.8% per year).
Ingresos de alto crecimiento: B8FE's revenue (22% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if B8FE's Return on Equity is forecast to be high in 3 years time